DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» GNF6702
GNF6702
Identification and Characterization of Novel Anti-Leishmanial Compounds
Ce Document Est Le Fruit D'un Long Travail Approuvé Par Le Jury De Soutenance Et Mis À Disposition De L'ensemble De La Communauté Universitaire Élargie
University of Dundee Anti-Trypanosomatid Drug Discovery
Aads. See Aminoacetonitrile Derivatives
The Proteasome As a Target: How Not Tidying up Can Have Toxic Consequences for Parasitic Protozoa Elizabeth A
Drug Discovery for Kinetoplastid Diseases: Future Directions † ‡ § ∥ Srinivasa P
New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
Versão Do Arquivo Anexado / Version of Attached File: Versão Do Editor / Published Version Mais Informações No Site Da Edito
Chemogenomic Profiling of Antileishmanial Efficacy And
Dissertation__Michael Berninger
Khare Et Al 2016
Preclinical Candidate for the Treatment of Visceral Leishmaniasis That Acts Through Proteasome Inhibition
Wakisa Kipandula Mphil Thesis
Chemogenomic Profiling of Anti-Leishmanial Efficacy and Resistance in The
Leishmanicidal Therapy Targeted to Parasite Proteases
The Future of Global Treatment of Cutaneous Leishmaniasis
University of Dundee Challenges and Recent
Universidade Estadual De Campinas Instituto De Biologia Thalita Camêlo Da Silva Ferreira Relevance of Multi-Species Phenotypic
Top View
Human African Trypanosomiasis, Chagas Disease and Leishmaniases
Need for Sustainable Approaches in Antileishmanial Drug Discovery
Challenges and Recent Progress in Drug Discovery for Tropical Diseases Manu De Rycker1, Beatriz Baragaña1, Suzanne L
The Design and Synthesis of Cyanines and Arylimidamide Azole
Experimental and Clinical Treatment of Chagas Disease: a Review
Anti-Trypanosomatid Drug Discovery: an Ongoing Challenge and a Continuing Need
(12) Patent Application Publication (10) Pub. No.: US 2017/0211121 A1 Stern Et Al
Maladie De Chagas : Épidémiologie, Impact Économique, Nouveaux Champs De Recherche Romain Perrette
WO 2017/127684 Al 27 July 2017 (27.07.2017) P O P C T
University of Dundee Challenges and Recent Progress in Drug
Lactacystin: first-In-Class Proteasome Inhibitor Still Excelling and an Exemplar for Future Antibiotic Research
Sleeping Sickness) the Road to Elimination Revisited—Achievements and Remaining Challenges
Computational Approaches for Drug Discovery Against Trypanosomatid Caused Diseases Claudio A. Pereira1,2,*, Melisa Sayé1,2